Tarsus Pharmaceuticals secures $125.0 million in oversubscribed Private Placement Equity Financing, led by Barclays with participation from TCGX and Bain Capital. The funds will support clinical development and corporate activities.
Amount Raised
$125 Million
Round Type
Post-IPO Equity
IrvineManufacturingBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaInvestors
Description
Tarsus Pharmaceuticals has entered into a securities purchase agreement for a $125.0 million PIPE financing, with participation from both existing and new investors. The financing includes the sale of common stock and pre-funded warrants. Funds will be used for clinical development and other corporate purposes. The deal is expected to close on August 7, 2026.
Quick answer
Tarsus Pharmaceuticals raised $125 Million in a Post-IPO Equity round, dated August 6, 2026. Investors: Vestal Point Capital, RTW Investments, Sirenia Capital Management LP, Adar1 Capital Management, Wellington Management, Bain Capital Life Sciences and Tcgx. Tarsus Pharmaceuticals is based in Irvine, California, United States.
- How much did Tarsus Pharmaceuticals raise?
- Tarsus Pharmaceuticals raised $125 Million in a Post-IPO Equity round on August 6, 2026.
- Who invested in Tarsus Pharmaceuticals?
- Vestal Point Capital, RTW Investments, Sirenia Capital Management LP, Adar1 Capital Management, Wellington Management, Bain Capital Life Sciences and Tcgx are named as investors in this round.
- What does Tarsus Pharmaceuticals do?
- Tarsus Pharmaceuticals, Inc. is a company specializing in biological products.
- Where is Tarsus Pharmaceuticals based and how big is it?
- Tarsus Pharmaceuticals is based in Irvine, California, United States. Fundz records about 370 employees.
- Who are the decision-makers at Tarsus Pharmaceuticals?
- Fundz holds 2 contacts at Tarsus Pharmaceuticals, including the Chief Commercial Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Pharmaceutical around the same time
Companies in the same sectors as Tarsus Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.
- Orvida Pharma raised an undisclosed amount on September 15, 2026.
- Cerenome, Inc. raised $3M (Post-IPO Equity) on September 10, 2026.
- Cerenome, Inc. raised $20M (Debt Financing) on September 10, 2026.
- Newron Pharmaceuticals S.p.A. & EA Pharma Ltd raised $6.4M on September 8, 2026.
- Dimerix Limited raised $25M (Debt Financing) on September 4, 2026.
- Redx raised $36M (Series A) on August 27, 2026.
Who to call at Tarsus Pharmaceuticals, and when
A new round usually means Tarsus Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Tarsus Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Tarsus Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Tarsus Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Tarsus Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Tarsus Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.